Durability of insulin degludec plus liraglutide versus insulin glargine U100 as initial injectable therapy in type 2 diabetes (DUAL VIII): a multicentre, open-label, phase 3b, randomised controlled trial
| Autor: | Aroda, Vanita R, González-Galvez, Guillermo, Grøn, Randi, Halladin, Natalie, Haluzík, Martin, Jermendy, György, Kok, Adri, Őrsy, Petra, Sabbah, Mohamed, Sesti, Giorgio, Silver, Robert |
|---|---|
| Zdroj: | In The Lancet Diabetes & Endocrinology August 2019 7(8):596-605 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|